Prevalence of Burkholderia cepacia recovered from clinical specimens at tertiary care hospital

Amit Kumar; Shilpi Gupta; Prachi Saban; Dipak Patanvadia; Deepak Deskar; Rekha Kishori; Pankti Pargi

doi:10.18203/2349-3933.ijam20250374

Authors

Amit Kumar Department of Microbiology, Zydus Medical College Dahod, Gujarat, India
Shilpi Gupta Department of Microbiology, Sri Aurobindo Medical College and PG Institute, Indore, M. P., India
Prachi Saban Department of Microbiology, National Institute of Medical Sciences and Research, NIMS University, Jaipur, Rajasthan, India
Dipak Patanvadia Department of Microbiology, Zydus Medical College, Dahod, Gujarat, India
Deepak Deskar Department of Microbiology, Zydus Medical College, Dahod, Gujarat, India
Rekha Kishori Department of Microbiology, Zydus Medical College, Dahod, Gujarat, India
Pankti Pargi Department of Microbiology, Zydus Medical College, Dahod, Gujarat, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20250374

Keywords:

Antimicrobial resistance, Burkholderia cepacia, Prevalence, Thoracic and vascular surgery

Abstract

Background: One of the multiple intrinsically resistant bacteria that cause opportunistic illnesses is Burkholderia cepacia. The distribution of B. cepacia isolates according to clinical specimen categories, hospital wards, patient gender and age, and antibiotic susceptibility assessment were the main objectives of the study.

Methods: This hospital based cross sectional study was conducted in department of microbiology at SAIMS Indore M. P. from May 2024 to June 2024. Relevant samples for e. g., blood, urine, sputum, body fluids, pus were collected as per institution collection protocol from inpatient and outpatient department.

Results: A total of 4875 clinical samples received for culture, 1738 samples were found positive of which 100 (2.015%) B. cepacia were isolated from various clinical samples (Table 1 and Figure 4). The majority of the 100 B. cepacia isolates were isolated from blood and respiratory samples (sputum, bronchoalveolar lavage, pleural fluid), followed by pus and urine samples, which accounted for 80 (80%), 12 (12%), 7 (7%) and 1 (1%) isolate, respectively.

Conclusions: B. cepacia is emerging cause of various clinical manifestations including septicemia with multi drug resistance that need to be treated quickly and effectively.

Metrics

Metrics Loading ...

References

Kenna DTD, Lilley D, Coward M, Martin K. Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients. J Med Microbiol. 2017;66(4):490-501. DOI: https://doi.org/10.1099/jmm.0.000458

Jones AM, Dodd ME, Webb AK. Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas. Eur Respir J. 2001;17(2):295-301. DOI: https://doi.org/10.1183/09031936.01.17202950

Suhartono S, Mahdani W, Muzayanna NN. Prevalence of Burkholderia cepacia recovered from clinical specimens in the Zainoel Abidin general hospital, Banda Aceh, Indonesia. Iran J Microbiol. 2023;15(1):38-44.

Gangaram U, Ramya T, Jithendra K, Mohan DR. Burkholderia cepacia an emerging cause of septicaemia, in an intensive care unit from a tertiary care hospital, Nellore, India. Int J Adv Med. 2020;7(3):413-7.

LiPuma JJ, Currie BJ, Peacock SJ, Vandamme PA. Burkholderia, Stenotrophomonas, Ralstonia, Cupriavidus, Pandoraea, Brevundimonas, Comamonas, Delftia, and Acidovorax, in Manual Clinical Microbiology ch. 43, Vol 1, 11th edition, Washington DC, USA, American Society for Microbiology. 2011;791-812. DOI: https://doi.org/10.1128/9781555816728.ch41

Levy I, Lenard L, Moshie D, Samra Z, Konisberger H, Ashkenazi S. A prospective study of Gram-negative bacteremia in children. Paediatr Infec Dis J. 1996;15(2):117-22. DOI: https://doi.org/10.1097/00006454-199602000-00006

Mandell GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 5th ed. Philadelphia: Churchill Livingstone. 2000.

Mac Faddin JF. Biochemical tests for identification of medical bacteria. 3 rd ed. Philadelphia, PA: Lippincott Williams and Wilkins. 2000:411-80.

McMenamin JD, Zaccone TM, Coenye T, Vandamme P, LiPuma JJ. Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers. Chest. 2000;117(6):1661-5. DOI: https://doi.org/10.1378/chest.117.6.1661

Omar N, El Raouf HA, Okasha H, Nabil N. Microbiological assessment of Burkholderia cepacia complex (BCC) isolates in Alexandria Main University Hospital. Alexand J Med. 2015;51(1):41-6. DOI: https://doi.org/10.1016/j.ajme.2014.08.005

Kady HE, Mohamed One, Abaza AF, Zidan YHM, Burkholderia Cepacia Complex Among Intensive Care Unit Patients in Two Private Hospitals in Alexandria. Inter J Sci Technol Res. 2018;7(1):102-9.

Gales AC, Jones RN, Andrade SS, Sader HS. Antimicrobial susceptibility patterns of unusual non-fermentative gram-negative bacilli isolated from Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2002). Memórias do Instituto Oswaldo Cruz. 2005;100(6):571-7. DOI: https://doi.org/10.1590/S0074-02762005000600011

Padma SS, Appalaraju B, Someshwaran R. Clinico-microbiological Profile and Antibiotic Susceptibility Pattern of BCC Isolates, J Clin Diagnost Res. 2023;17(10):DC01-8.

Suhartono S, Mahdani W, Muzayanna NN. Prevalence of Burkholderia cepacia recovered from clinical specimens in the Zainoel Abidin general hospital, Banda Aceh, Indonesia. Iran J Microbiol. 2023;15(1):38-44. DOI: https://doi.org/10.18502/ijm.v15i1.11916

Gangaram U, Ramya T, Jithendra K, Mohan DS. Burkholderia cepacia an emerging cause of septicaemia, in an intensive care unit from a tertiary care hospital, Nellore, India. Int J Adv Med. 2020;7(3):413-7. DOI: https://doi.org/10.18203/2349-3933.ijam20200591